240 related articles for article (PubMed ID: 24001612)
1. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain.
Wu CP; Zhou L; Gong HL; Du HD; Tian J; Sun S; Li JY
Cancer Lett; 2014 Jan; 342(1):92-103. PubMed ID: 24001612
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of a HPV-negative cell line derived from xenografted human laryngeal squamous cell carcinoma].
Cai P; Wu ZY; Li JR; Liu GH; Hua QQ; Zhan HZ
Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):533-6. PubMed ID: 16383303
[TBL] [Abstract][Full Text] [Related]
3. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.
Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V
J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904
[TBL] [Abstract][Full Text] [Related]
4. Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer cell lines.
Nichols AC; Yoo J; Palma DA; Fung K; Franklin JH; Koropatnick J; Mymryk JS; Batada NN; Barrett JW
Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):732-9. PubMed ID: 22911296
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑503 serves an oncogenic role in laryngeal squamous cell carcinoma via targeting programmed cell death protein 4.
Shuang Y; Zhou X; Li C; Huang Y; Zhang L
Mol Med Rep; 2017 Oct; 16(4):5249-5256. PubMed ID: 28849168
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1.
Liu Y; Liu J; Wang L; Yang X; Liu X
Mol Med Rep; 2017 Nov; 16(5):7154-7162. PubMed ID: 28901478
[TBL] [Abstract][Full Text] [Related]
8. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
9. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
[TBL] [Abstract][Full Text] [Related]
10. [The relationship of p53 gene mutation to cell differentiation and metastasis of laryngeal squamous cell carcinoma].
Zhang X; Wang L; Liu S; Ouyang X; Liang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):61-3. PubMed ID: 11836691
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
[TBL] [Abstract][Full Text] [Related]
14. [The mutation and expression of MUS81 gene in laryngeal squamous cell carcinoma].
Li C; Wang S; Yuan H; Li W; Li Z; Li X; Guo X; Li F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):560-5. PubMed ID: 18841572
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
16. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma.
Shi Y; Gong HL; Zhou L; Tian J; Wang Y
ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):78-85. PubMed ID: 22354323
[TBL] [Abstract][Full Text] [Related]
17. DIAPH1 Is Upregulated and Inhibits Cell Apoptosis through ATR/p53/Caspase-3 Signaling Pathway in Laryngeal Squamous Cell Carcinoma.
Yang J; Zhou L; Zhang Y; Zheng J; Zhou J; Wei Z; Zou J
Dis Markers; 2019; 2019():6716472. PubMed ID: 30733838
[TBL] [Abstract][Full Text] [Related]
18. [Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma].
Hu A; Jin X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):788-92. PubMed ID: 23259291
[TBL] [Abstract][Full Text] [Related]
19. ASAP1 mediates the invasive phenotype of human laryngeal squamous cell carcinoma to affect survival prognosis.
Li M; Tian L; Yao H; Lu J; Ge J; Guo Y; Liu M; Xiao H
Oncol Rep; 2014 Jun; 31(6):2676-82. PubMed ID: 24788532
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA MYLK serves as an oncogene to promote cancer progression via microRNA-195/cyclin D1 axis in laryngeal squamous cell carcinoma.
Duan X; Shen N; Chen J; Wang J; Zhu Q; Zhai Z
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31427478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
